Viewing Study NCT03329950


Ignite Creation Date: 2025-12-24 @ 4:50 PM
Ignite Modification Date: 2026-02-22 @ 1:00 PM
Study NCT ID: NCT03329950
Status: COMPLETED
Last Update Posted: 2024-03-28
First Post: 2017-10-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
Sponsor: Celldex Therapeutics
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CDX1140-01
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View